ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Cancer.

MLA

Expert Panel on Urological Imaging, et al. “ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Cancer.” Journal of the American College of Radiology, vol. 16, no. 11, Nov. 2019, pp. S399–416. EBSCOhost, https://doi.org/10.1016/j.jacr.2019.05.022.

APA

Expert Panel on Urological Imaging, Purysko, A. S., Nikolaidis, P., Dogra, V. S., Ganeshan, D., Gore, J. L., Gupta, R. T., Heilbrun, M. E., Khatri, G., Kishan, A. U., Lyshchik, A., Savage, S. J., Smith, A. D., Wang, Z. J., Wolfman, D. J., Wong-You-Cheong, J. J., Yoo, D. C., & Lockhart, M. E. (2019). ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Cancer. Journal of the American College of Radiology, 16(11), S399–S416. https://doi.org/10.1016/j.jacr.2019.05.022

Chicago

Expert Panel on Urological Imaging, Andrei S Purysko, Paul Nikolaidis, Vikram S Dogra, Dhakshinamoorthy Ganeshan, John L Gore, Rajan T Gupta, et al. 2019. “ACR Appropriateness Criteria® Post-Treatment Follow-up and Active Surveillance of Clinically Localized Renal Cell Cancer.” Journal of the American College of Radiology 16 (11): S399–416. doi:10.1016/j.jacr.2019.05.022.